Managing the Neuropsychiatric Adverse Effects of Interferon Treatment

ISSN： 1173-8804

Source： BioDrugs, Vol.11, Iss.4, 1999-04, pp. : 229-237

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon Alfacon-1: A Novel Interferon for the Treatment of Chronic Hepatitis C

By Alberti A.

BioDrugs, Vol. 12, Iss. 5, 1999-11 ,pp. : 343-357

Adis International

Access to resources Recommend Favorite

Everolimus for treatment of tuberous sclerosis complex‐associated neuropsychiatric disorders

Annals Of Clinical And Translational Neurology, Vol. 4, Iss. 12, 2017-12 ,pp. : 877-887

John Wiley & Sons Inc

Access to resources Recommend Favorite

Managing Adverse Events Associated with Botulinum Toxin Type A: A Focus on Cosmetic Procedures

By Wollina Uwe Konrad Helga

American Journal of Clinical Dermatology, Vol. 6, Iss. 3, 2005-01 ,pp. : 141-150

Adis International

Access to resources Recommend Favorite

Interferon- Alone versus Interferon- plus Ribavirin in Patients with Chronic Hepatitis C Not Responding to Previous Interferon- Treatment

By Tripi S.

BioDrugs, Vol. 13, Iss. 4, 2000-04 ,pp. : 299-304

Adis International

Access to resources Recommend Favorite

Prolonged neuropsychiatric effects following management of chloroquine intoxication with psychotropic polypharmacy

Clinical Case Reports, Vol. 3, Iss. 6, 2015-06 ,pp. : 379-387

John Wiley & Sons Inc

Access to resources Recommend Favorite